COMMUNIQUÉS West-GlobeNewswire

Agios Presents Updated Phase 1 Data from Dose Expansion Cohort of Ivosidenib (AG-120) in Patients with IDH1 Mutant Positive Glioma

17/11/2017 - 13:05

- Durable Stable Disease and Reduction of Tumor Growth Rates Observed for Patients with Low Grade Glioma; Median Treatment Duration of 16 Months with 51% of Patients Still on Treatment – - Ivosidenib Well-tolerated in [...]

ZIOPHARM Oncology to Host Conference Call on November 20, 2017 at 10:15 a.m. ET to Discuss Updated Clinical Data Presented at the 2017 Annual Meeting of the Society for Neuro-Oncology

17/11/2017 - 13:00

BOSTON, Nov. 17, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP ), a biopharmaceutical company developing new gene and cell-based immunotherapies for cancer, today announced that it will host a [...]

ReWalk Robotics Announces Pricing of Follow-on Public Offering of Ordinary Shares

17/11/2017 - 12:50

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ) (“ ReWalk ” or the “ Company ”) today announced that it has priced its underwritten public offering of [...]

Digirad Corporation to Present at the 10th Annual LD Micro Main Event

17/11/2017 - 12:00

SUWANEE, Ga., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD ) announced today that it will be presenting at the 10 th annual LD Micro Main Event taking place December 5-7, 2017 at the Luxe Sunset [...]

Sentia Medical Sciences Inc. Announces the Launch of a New Initiative in Stress-related Disorders Targeting Gastrointestinal and Endocrine Diseases

17/11/2017 - 09:01

SAN DIEGO, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Sentia announced today that it will bring to fruition several decades of academic research by developing a new generation of first in class drug candidates called astressins [...]

NeuroSearch upgrades its guidance for 2017

17/11/2017 - 08:00

Company announcement 17 November 2017 NeuroSearch upgrades its guidance for 2017 from an operating loss of DKK 2.3-3.3 million, to an operation loss of approximately DKK 1 million. T he outlook does not include any [...]

Celyad Announces Third Quarter 2017 Business Update

17/11/2017 - 07:00

MONT-SAINT-GUIBERT, Belgium, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris: CYAD ) (NASDAQ: CYAD ), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T [...]

Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen

17/11/2017 - 03:30

Company Announcement Genmab to receive milestone payment of USD 50 million in DARZALEX collaboration Milestone triggered by sales of DARZALEX reaching USD 1 billion in a calendar year Copenhagen, Denmark; November 17, [...]

scPharmaceuticals Inc. Announces Pricing of Initial Public Offering

17/11/2017 - 03:05

BURLINGTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company”) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way [...]

Devonian Announces the Filing of New Patent Application for Thykamine™

17/11/2017 - 02:45

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD [...]

Devonian annonce le dépôt d'une nouvelle demande de brevet pour le Thykamine(MC)

17/11/2017 - 02:45

NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 16 nov. 2017 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) une société [...]

Karmanos Cancer Institute presents its 2017 Heroes of Cancer

16/11/2017 - 23:52

DETROIT , Nov. 16, 2017 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute presented its 2017 Heroes of Cancer at an awards ceremony held Nov. 15, recognizing champions in 15 award categories: individuals and [...]

NADP Analysis Shows Adults with Medicaid Preventive Dental Benefits Have Lower Medical Costs for Chronic Conditions

16/11/2017 - 23:15

DALLAS, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Recent Medical Expenditure Panel Survey (MEPS) data reveals an opportunity for states to provide both better care for the Medicaid population and potentially reduce the [...]

Voyager Therapeutics Highlights Lead Program VY-AADC for Advanced Parkinson’s Disease, AAV Novel Capsid and Delivery Optimization Efforts, and Pipeline Programs at its R&D Day

16/11/2017 - 22:45

CAMBRIDGE, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]

Emblem Completes Bought Deal Financing

16/11/2017 - 22:35

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (" Emblem " or the " Company ") is pleased [...]

SeaSpine to Participate in the 29th Annual Piper Jaffray Healthcare Conference

16/11/2017 - 22:15

CARLSBAD, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Precipio To Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time

16/11/2017 - 22:15

NEW HAVEN, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), today announced it will issue financial results for the Third Quarter ended September 30, 2017 and provide an update on corporate [...]

Vericel to Present at 29th Annual Piper Jaffray Healthcare Conference

16/11/2017 - 22:10

CAMBRIDGE, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, [...]

Neuralstem Announces Presentation of Clinical Data for NSI-189 in Major Depressive Disorder at the Upcoming American College of Neuropsychopharmacology Annual Meeting

16/11/2017 - 22:05

GERMANTOWN, Md., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that data from the Company’s Phase [...]